Search results for "asthma"

showing 10 items of 860 documents

Effects of exercise training and montelukast in children with mild asthma

2008

Data from the general population suggest that habitual exercise decreases bronchial responsiveness, but the possible role of exercise in asthmatics is undefined. The leukotriene receptor antagonist montelukast decreases bronchial responsiveness and exercise-induced symptoms in asthmatic children. This randomized study in children with mild asthma evaluated the combined effects of aerobic training for 12 wk and montelukast or placebo on bronchial responsiveness (BHR) to methacholine, exercise-induced bronchoconstriction (EIB), inflammatory markers in exhaled breath condensate (EBC), and asthma exacerbations.Fifty children (mean age +/- SD: 10.2 +/- 2.4 yr) with mild stable asthma were random…

CyclopropanesMaleQuinolineAcetatesSettore BIO/09 - Fisiologiaimmune system diseasesMedicineOrthopedics and Sports MedicineAnti-Asthmatic AgentsChildMethacholine ChlorideLeukotrieneeducation.field_of_studyrespiratory systemExercise TherapyAsthma Exercise-InducedBreath TestsItalyExhalationAnesthesiaQuinolinesFemalemedicine.drugHumanmedicine.medical_specialtyBreath TestBronchoconstrictionPopulationPhysical Therapy Sports Therapy and RehabilitationPhysical exerciseSulfidesSettore MED/10 - Malattie Dell'Apparato RespiratorioInternal medicineAerobic exerciseHumansAnti-Asthmatic AgenteducationMontelukastAsthmabusiness.industryLeukotriene receptorAcetateBronchospirometrymedicine.diseaseAsthmarespiratory tract diseasesPhysical FitnessPhysical FitneExercise TestMethacholinebusiness
researchProduct

Can the response to Omalizumab be influenced by treatment duration? A real-life study

2017

Objective It is unknown whether Omalizumab effectiveness changes over the course of time. Our retrospective real-life study tried to analyze whether Omalizumab response may be influenced by treatment duration. Methods 340 severe asthmatics treated with Omalizumab for different periods of time were recruited. They were subdivided into 4 groups according to the Omalizumab treatment length: 60 months. Omalizumab treatment results (FEV1, exacerbations, ACT, SABA use, asthma control levels, medications used e and ICS doses) were compared. Results ACT, exacerbations, GINA control levels, ICS doses and SABA use were similar in all groups with different Omalizumab treatment durations. Using a linea…

CyclopropanesMaleSevere asthmaTime FactorsTreatment durationQuinolineEffectivenessOmalizumabOmalizumabAcetatesAdrenal Cortex Hormone0302 clinical medicineAdrenal Cortex HormonesRetrospective StudieForced Expiratory VolumeMedicinePharmacology (medical)Anti-Asthmatic Agents030212 general & internal medicineLead (electronics)Adrenergic beta-AgonistConfoundingEffectiveneReal-lifeResponseAdrenergic beta-AgonistsMiddle AgedTreatment OutcomeEffectiveness; Omalizumab; Real-life; Response; Severe asthma; Treatment duration; Pulmonary and Respiratory Medicine; Biochemistry (medical); Pharmacology (medical)QuinolinesLinear ModelFemaleHumanmedicine.drugAdultPulmonary and Respiratory Medicinemedicine.medical_specialtyTime FactorSulfidesSettore MED/10 - Malattie Dell'Apparato RespiratorioTreatment duration03 medical and health sciencesInternal medicineHumansAnti-Asthmatic AgentMontelukastRetrospective StudiesAsthmaAcetatebusiness.industryBiochemistry (medical)Retrospective cohort studymedicine.diseaseAsthmaDiscontinuationSurgery030228 respiratory systemLinear ModelsbusinessPulmonary Pharmacology & Therapeutics
researchProduct

Roflumilast for asthma: Weighing the evidence

2015

CyclopropanesPulmonary and Respiratory Medicinebusiness.industryAdrenal cortex hormonesBiochemistry (medical)AminopyridinesPharmacologyPlacebomedicine.diseaseAsthmaAdrenal Cortex HormonesAdministration InhalationBenzamidesHumansMedicinePharmacology (medical)Phosphodiesterase 4 InhibitorsbusinessRoflumilastAsthmamedicine.drugAminopyridinesPulmonary Pharmacology & Therapeutics
researchProduct

Cytokine Production Profile Of T-lymphocytes In Patients With Allergic Asthma Receiving Anti-IgE Therapy

2010

Cytokinebiologybusiness.industrymedicine.medical_treatmentImmunologybiology.proteinMedicineIn patientAllergic asthmaImmunoglobulin EbusinessD32. HUMAN STUDIES OF IMMUNE DYSFUNCTION IN ASTHMA
researchProduct

The respiratory microbiome in bronchial mucosa and secretions from severe IgE-mediated asthma patients

2017

Altres ajuts: This work was supported by Fundació Catalana de Neumología (FUCAP) and Centro de Investigación Biomédica en Red de Enfermedades Respiratorias(CIBERES). CIBERES is an initiative of the Instituto de Salud Carlos III. The bronchial microbiome in chronic lung diseases presents an abnormal pattern, but its microbial composition and regional differences in severe asthma have not been sufficiently addressed. The aim of the study was to describe the bacterial community in bronchial mucosa and secretions of patients with severe chronic asthma chronically treated with corticosteroids in addition to usual care according to Global Initiative for Asthma. Bacterial community composition was…

DNA BacterialMale0301 basic medicineMicrobiology (medical)BiopsyMicrobial ConsortiaBronchimedicine.disease_causeImmunoglobulin EMicrobiology03 medical and health sciencesRNA Ribosomal 16SBronchoscopymedicinePrevotellaHumansMicrobiomeAsthmaMucous MembraneLungBacteriabiologyStreptococcusSputumFusobacteriaBiodiversitySequence Analysis DNAImmunoglobulin EMiddle Agedmedicine.diseasebiology.organism_classificationAsthmaCross-Sectional Studies030104 developmental biologymedicine.anatomical_structureImmunologybiology.proteinMetagenomeSputumFemaleMicrobiomemedicine.symptomBronchial aspirateResearch Article
researchProduct

The incidence of influenza-associated hospitalizations in children in Germany

2002

Since new vaccines and anti-viral drugs for influenza have become available, collation of actual and country-specific epidemiological data is essential. Since respiratory syncytial virus (RSV) is a well known paediatric airway pathogen and some epidemiological data exist already, a comparison between influenza and RSV seems warranted. From July 1996 to June 2001 the naso-pharyngeal aspirates (NPA) of children from birth to 16 years of age, admitted to one of the two paediatric hospitals in Kiel, Germany, were investigated by a nine-valent multiplex reverse transcriptase PCR assay. NPA were investigated in 60·8% of 3469 children admitted with an acute respiratory tract infection. Community-a…

DNA BacterialMalemedicine.medical_specialtyPediatricsAdolescentHeart DiseasesEpidemiologyPopulationOrthomyxoviridaeRespiratory Syncytial Virus InfectionsRisk FactorsGermanyNasopharynxInfluenza HumanEpidemiologymedicineHumansChildeducationAcute respiratory tract infectionAsthmaeducation.field_of_studybiologyReverse Transcriptase Polymerase Chain Reactionbusiness.industryIncidenceIncidence (epidemiology)Infant NewbornInfantvirus diseasesmedicine.diseasebiology.organism_classificationAsthmaHospitalizationVaccinationInfectious DiseasesChild PreschoolFemaleViral diseasebusinessResearch ArticleEpidemiology and Infection
researchProduct

Nebulized Beclomethasone In The Treatment Of Childhood Mild Intermittent Asthma With Seasonal Allergic Rhinitis. A Randomized, Double-Blind, Placebo-…

2010

Double blindPediatricsmedicine.medical_specialtybusiness.industryPlacebo-controlled studymedicineMild intermittent asthmabusinessC37. EXERCISE, AEROSOLS AND AIRWAY DYNAMICS
researchProduct

Local oropharyngeal side effects of inhaled corticosteroids in patients with asthma.

2006

The widespread use of inhaled corticosteroids (ICS) for the treatment of persistent asthma, although highly effective, may be associated with both systemic and local side effects. Systemic side effects of ICS have been extensively studied. In contrast, relatively few studies have been performed to specifically evaluate local side effects of ICS. These local side effects--including oropharyngeal candidiasis, dysphonia, pharyngitis, and cough--are generally viewed as minor complications of therapy. However, they can be clinically significant, affect patient quality of life, hinder compliance with therapy, and mask symptoms of more serious disease. Local side effects result from deposition of …

DrugAdultmedicine.medical_specialtyAllergymedicine.drug_classmedia_common.quotation_subjectImmunologyOropharynxCiclesonideOropharyngeal Candidiasischemistry.chemical_compoundAdrenal Cortex HormonesAdministration InhalationmedicineImmunology and AllergyHumansIntensive care medicineChildmedia_commonAsthmaVoice DisordersInhalationbusiness.industryCandidiasisPharyngitismedicine.diseasePharyngitisAsthmachemistryCoughAnesthesiaCorticosteroidmedicine.symptombusinessAllergy
researchProduct

Protective Effect Of Disodium Cromoglycate In Exercise-induced Asthma In Adults And Its Synergistic Effect In A Fixed Drug Combination With Reproterol

2010

DrugExercise-induced asthmabusiness.industrymedia_common.quotation_subjectDisodium cromoglycatemedicineReproterolPharmacologymedicine.diseasebusinessmedicine.drugmedia_commonD101. DIAGNOSIS AND TREATMENT OF ASTHMA
researchProduct

Use of ICS/LABA (extra-fine and non-extra-fine) in elderly asthmatics.

2016

Age represents an exclusion criterion in randomized clinical trials designed to test the efficacy and safety of inhaled drugs in asthma. As a consequence, data on efficacy and safety of inhaled corticosteroid (ICS) and long-acting β2 agonist (LABA) combinations in elderly asthmatics are scanty. Older age is associated with an increased proportion of comorbid conditions; in addition, all organ functions undergo a process of senescence, thus reducing their ability to metabolize the agents. Overall, these age-associated conditions may variably, and often unpredictably, affect the metabolism and excretion of respiratory drugs. However, pharmacological treatment of asthma does not follow specifi…

Druglong-acting β2 agonistmedicine.medical_specialtyasthma treatmentmedia_common.quotation_subjectPopulationReviewSettore MED/10 - Malattie Dell'Apparato Respiratorio030204 cardiovascular system & hematologylaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled trialPharmacokineticsInhaled corticosteroidlawmedicinePharmacology (medical)General Pharmacology Toxicology and PharmaceuticseducationAdverse effectIntensive care medicineAsthmamedia_commoneducation.field_of_studyChemical Health and SafetyInhalationbusiness.industryaginglung functionGeneral Medicinemedicine.diseasecomorbidity030228 respiratory systemAnesthesiaPharmacodynamicslong-acting β2 agonistsinhaled corticosteroidsbusinessSafety ResearchTherapeutics and clinical risk management
researchProduct